홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Diisopropylethylamine → 1-{1-[4-(3-(N,N-di-tert-butoxycarbonylaminomethyl)phenyl)-piperidin-1-yl]-methanoyl}-3-methylsulfanyl-6,7-dihydro-5H-benzo[c]thiophen-4-one

HRID 489603
인쇄

반응식

HRID 489603 반응식
F[B-](F)(F)F.N1(OC(N(C)C)=[N+](C)C)C2C=CC=CC=2N=N1.[CH3:23][S:24][C:25]1[S:29][C:28]([C:30]([OH:32])=O)=[C:27]2[CH2:33][CH2:34][CH2:35][C:36](=[O:37])[C:26]=12.C(N(C(C)C)CC)(C)C.[C:47]([O:51][C:52]([N:54]([CH2:62][C:63]1[CH:64]=[C:65]([CH:69]2[CH2:74][CH2:73][NH:72][CH2:71][CH2:70]2)[CH:66]=[CH:67][CH:68]=1)[C:55]([O:57][C:58]([CH3:61])([CH3:60])[CH3:59])=[O:56])=[O:53])([CH3:50])([CH3:49])[CH3:48]>CN(C)C=O>[C:58]([O:57][C:55]([N:54]([CH2:62][C:63]1[CH:64]=[C:65]([CH:69]2[CH2:70][CH2:71][N:72]([C:30]([C:28]3[S:29][C:25]([S:24][CH3:23])=[C:26]4[C:36](=[O:37])[CH2:35][CH2:34][CH2:33][C:27]=34)=[O:32])[CH2:73][CH2:74]2)[CH:66]=[CH:67][CH:68]=1)[C:52]([O:51][C:47]([CH3:50])([CH3:49])[CH3:48])=[O:53])=[O:56])([CH3:59])([CH3:60])[CH3:61]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 81531Diisopropylethylamine2회HCID 6583903-methylsulfanyl-4-oxo-6,7-dihydro-5H-2-benzothiophene-1-carboxylic acidHCID 2733207O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborateHCID 222661574-[3-(N,N-di-tert-butoxycarbonylaminomethyl)phenyl]piperidine

생성물 1

HCID 22266077
1-{1-[4-(3-(N,N-di-tert-butoxycarbonylaminomethyl)phenyl)-piperidin-1-yl]-methanoyl}-3-methylsulfanyl-6,7-dihydro-5H-benzo[c]thiophen-4-one

시약·촉매·용매 1

HCID 6228Dimethylformamide용매2회

실험 절차

2-(1H-Benzotriazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate (TBTU) (120 mg, 0.38 mmol) was added to a room temperature solution of 3-methylsulfanyl-4-oxo-4,5,6,7-tetrahydro-benzo[c]thiophene-1-carboxylic acid (88 mg, 0.36 mmol) and diisopropylethylamine (140 mg, 1.08 mmol) in dimethylformamide (2 mL), under nitrogen. The reaction mixture was stirred for 10 minutes at room temperature before adding a solution of 4-[3-(N,N-di-tert-butoxycarbonylaminomethyl)phenyl]piperidine (140 mg, 0.36 mmol) and diisopropylethylamine (140 mg, 1.08 mmol) in dimethylformamide (2 mL). The reaction mixture was stirred at room temperature for 16 hours, concentrated to dryness in vacuo, and subjected to dry flash column chromatography on silica with 50:50, dichloromethane:ethyl acetate. 1-{1-[4-(3-(N,N-di-tert -butoxycarbonylaminomethyl)phenyl)-piperidin-1-yl]-methanoyl}-3-methylsulfanyl-6,7-dihydro-5H-benzo[c]thiophen-4-one was isolated as a colorless oil (177 mg). The intermediate was dissolved in dichloromethane (20 mL), cooled at 0° C., and treated with trifluoroacetic acid (2 mL). The reaction mixture was stirred at room temperature under nitrogen for 2 hours, and concentrated to dryness in vacuo. The residue was dissolved in 20% acetonitrile/water [containing 0.1% trifluoroacetic acid] (9 mL) and purified by preparative reverse-phase HPLC (C-18, 10 micron reverse-phase column), eluting with 10% to 100% acetonitrile/water (containing 0.1% trifluoroacetic acid). The product fractions were combined and the acetonitrile removed in vacuo. The aqueous residue was frozen and lyophilized to give the title compound as an amorphous white solid (122 mg, 64%). 1H NMR [(CD3)2SO]: δ 8.16 (br s, 3H, NH3+); 7.41-7.24 (m, 4H); 4.21 (br d, 2H); 4.03 (q, 2H); 3.18-3.02 (m, 2H); 2.91-2.72 (m, 3H); 2.59 (s, 3H); 2.53-2.41 (m, 2H); 1.98-1.90 (m, 2H); 1.90-1.79 (m, 2H); 1.68-1.50 (m, 2H). MS(Ion spray): 415 (M++1).

후처리

  1. stirringThe reaction mixture was stirred at room temperature for 16 hours
  2. concentrationconcentrated to dryness in vacuo
  3. dry with materialto dry flash column chromatography on silica with 50:50, dichloromethane

출처 및 근거

ORD 기록
ord-0431cdf1071344ccaba9e4f3123cf102
출처 데이터셋
uspto-grants-2005_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06977263B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트